CooperCompanies announced the appointment of Colleen Jay as the new Chair of the Board of Directors, effective January 2, 2026, succeeding current Chair Robert Weiss. The Company also initiated a formal strategic review to enhance long-term shareholder value, focusing on improving performance, expanding market share, and generating strong returns through capital deployment initiatives. Colleen Jay, who has served on the Board since 2016, retired from Procter & Gamble in 2017 after 32 years of increasing responsibility. The Board and Management are undergoing a comprehensive review of the Company’s businesses, strategy, and operations. CooperCompanies operates through two business units, CooperVision and CooperSurgical, impacting over fifty million lives annually.

Read more at GlobeNewswire: CooperCompanies Announces New Chair of the Board and